Brand Institute

What Brand Institute does

Brand Institute is a privately-held, Miami-headquartered brand identity consultancy founded in 1993 by James L. Dettore. The firm specializes in pharmaceutical and biopharmaceutical brand naming, nonproprietary naming (INN/USAN), regulatory strategy, trademark clearance, market research, and visual identity development. Its core clients are large pharmaceutical and biotech companies developing prescription drugs, where government regulatory approval of a brand name is a prerequisite to market entry. The company also serves consumer brands (PepsiCo, P&G, BMW, L'Oréal, Kenvue) and selected technology/medical-device clients. Brand Institute is recognized as the world's #1 naming company, partnering on 75%+ of global Rx name approvals and holding dominant 2025 approval shares at the FDA (88%), EMA (76%), Health Canada (97%), Japan (76%), South Korea (79%), Brazil (79%), China (78%), and India (72%).

The firm's competitive position rests on its wholly-owned regulatory subsidiary Drug Safety Institute (DSI), established in 2004, which is staffed by former naming officials from the FDA, EMA, Health Canada, AMA, and WHO who co-authored the agencies' naming review guidelines. DSI's methodology is the de facto standard for FDA proprietary name safety testing. Brand Institute's proprietary AI platform Brandi generates pharmaceutical name candidates and screens them against 200,000+ existing names across 41 languages; in April 2026, an AI-assisted brand name generated via Brandi received the first EMA approval for any AI-developed pharmaceutical name. BI•Q™, launched May 2025, is the umbrella suite for AI-powered branding solutions.

The company operates 19 offices across North America, Europe, Asia, and South America, sells through a B2B professional-services model with direct enterprise sales teams, and prices services on a quote-based, project-specific basis. It is founder-controlled, employs 101-250 people, and has created 6,000+ brand names and 1,700+ INN/USAN names across its history. Approximately 2/3 of the world's largest pharmaceutical companies are among its 1,500+ client roster.

Name

Brand Institute

Legal name

Brand Institute, Inc.

Website

https://brandinstitute.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

251–500 employees

Short description

Brand Institute is a privately-held Miami-based brand naming consultancy founded in 1993, specializing in pharmaceutical and biotech drug name development, regulatory submissions, and visual identity. It partners on 75%+ of global Rx name approvals via its Drug Safety Institute subsidiary and proprietary Brandi AI platform.

Ownership category

akta.pro rank

Product category

Brand Naming and Regulatory Services

NAICS

Advertising Agencies (541810)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Brand Consulting, Audits & Research (Brand Health, Equity, Competitive) (BPAFAEAJ)

akta.pro secondary industries

Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH), Regulatory Affairs, Labeling & Advertising/Promotion Compliance (HLAJADAI)

Keywords

• Pharmaceutical brand naming
• Drug name development
• Regulatory naming services
• Brand identity consultancy
• Trademark clearance services

Headquarters

HQ city

Miami

HQ country

United States

HQ region

North America

Offices19 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Brand Naming and Development Services: Professional services including brand name development, corporate identity development, visual identity design, trademark searches, market research, and regulatory services for pharmaceutical, biotech, and consumer companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Brand Institute is a B2B brand naming and identity consultancy that develops brand names, corporate identities, visual identities, and conducts trademark searches, market research, and regulatory services for pharmaceutical, biotech, consumer, and B2B companies. The company operates a wholly-owned regulatory subsidiary, Drug Safety Institute (DSI), staffed by former officials from the FDA, EMA, Health Canada, AMA, and WHO, providing pharmaceutical name safety analysis and regulatory submissions.

Product overview

Brand Institute is the world's #1 naming company offering a comprehensive portfolio of brand naming, market research, regulatory, and visual identity services. The company operates two primary offerings: (1) Brand Institute's core naming services including Strategy Services, Name Development, Trademark Searches, Market Research, Regulatory Services, and Visual Identity; and (2) Drug Safety Institute (DSI), a wholly-owned regulatory subsidiary providing name safety analysis and regulatory guidance through former naming officials from FDA, EMA, Health Canada, AMA, and WHO. The company has recently expanded into AI-powered solutions with the BI•Q™ suite, which includes the Brandi AI name generation platform that achieved the first-ever EMA approval for an AI-assisted pharmaceutical brand name in April 2026. Brand Institute has been in business for 30+ years and partners on over 75% of drug name approvals worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Drug Safety Institute (DSI): Wholly-owned regulatory subsidiary providing pharmaceutical name safety research, packaging, and labeling services. Composed of former naming officials from FDA, EMA, Health Canada, AMA, and WHO.
• Brandi
• BI•Q™

Products and services

• Strategy Services
• Name Development Diverse team of experienced namers developing hand-crafted names supported by AI-powered technology. Covers brand names, corporate names, clinical trial names, nonproprietary names, and line extensions for enterprise clients.
• Trademark Searches In-house team of attorneys and paralegals performing efficient and comprehensive global trademark screening, analysis, and strategy guidance for brand name clearance.
• Market Research Online naming and visual identity research surveys using a global panel of respondents, with results benchmarked to historical norms for pharmaceutical, consumer, and corporate identity research.
• Regulatory Services Industry-leading name safety research, regulatory strategy, reports, rebuttals, and consults. Includes pharmaceutical name safety analysis, promotional name review, USAN/INN development, and product labeling/packaging review through Drug Safety Institute.
• Visual Identity Award-winning designers creating dynamic logos, packaging and labeling, collateral material, and websites for brand development.
• Drug Safety Institute (DSI) Wholly-owned regulatory subsidiary of Brand Institute providing industry-leading guidance on drug name safety, packaging, and labeling. Composed of former naming officials from the FDA, EMA, Health Canada, AMA, and WHO who co-authored name review guidelines.
• BI•Q™ (AI-Powered Branding Solutions) Suite of AI-Powered Branding Solutions launched in May 2025, combining artificial intelligence with human curation for name development, refinement, and regulatory compliance. Umbrella brand encompassing Brand Institute's proprietary AI naming and branding capabilities.
• Brandi (AI Name Generation Platform) Proprietary AI-powered name generation platform that rapidly produces viable pharmaceutical brand name candidates that human teams curate, refine, and develop. Screens against 200,000+ existing names and performs linguistic evaluation across 41 languages. Achieved first-ever EMA approval for an AI-assisted pharmaceutical brand name in April 2026.

Quantifiable outcome

• 88% share of 2025 FDA Rx name approvals
• +3 more outcomes

Named customers30 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature2 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Nutriband Inc.coreStrategic or Co-development Partner · 30 March 2026Brand Institute partnered with Nutriband Inc. to develop a commercial worldwide brand name for its abuse-deterrent fentanyl transdermal system using AVERSA technology. The brand name was submitted to FDA and other international regulatory agencies for approval. Nutriband projects peak annual US sales of $80 million to $200 million for the product, which has potential to be the world's first such product designed to deter abuse, misuse, and accidental exposure of transdermal fentanyl. Drug Safety Institute supported with regulatory services.
• Nova Southeastern University College of PharmacyminorStrategic or Co-development PartnerEstablished partnership with Nova Southeastern University College of Pharmacy to create the Stephanie Feldman Aleong National Patient Safety Award, presented annually to healthcare industry leaders and patient advocates whose efforts have significantly advanced patient safety.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• IQVIA: Global life-sciences services giant providing clinical, RWE, and commercial services to pharma. It is a credible strategic acquirer of Brand Institute and overlaps in commercial/brand strategy and market research for pharma clients.
• Clarivate (Brand Landscape / trademark): Provider of trademark and brand-IP intelligence (CompuMark/Darts-ip) alongside life-sciences regulatory intel; overlaps with Brand Institute's trademark clearance and regulatory research work, though its primary focus is data and software not creative naming.
• Kantar (Millward Brown): Global market-research and brand measurement giant; overlaps with Brand Institute's market research, brand equity tracking, and naming research modules but sits within a much broader portfolio of research and consulting services.

Direct peers

• Lippincott: Brand strategy and naming firm with a strong healthcare and pharma client base; directly comparable in delivering naming, brand architecture, and identity work to enterprise pharma and consumer clients.
• Interbrand: Global brand strategy and naming consultancy operating across industries including healthcare. Directly competes for consumer and B2B brand naming engagements with the same agency model and creative-led pitch process used by Brand Institute.
• Landor & Fitch: Large global branding agency with explicit healthcare and pharma brand-naming practice. Competes head-to-head with Brand Institute for the same Fortune 500 pharmaceutical and consumer clients on naming, identity, and architecture engagements.
• Siegel+Gale: Brand strategy and naming consultancy (part of Brand Consulting Group / Omnicom) with a dedicated health and pharma practice; competes for biotech, consumer health, and medical device naming projects similar to Brand Institute's pharma book.
• FutureBrand (Interpublic Group): Interpublic-owned global brand consultancy with a healthcare/naming offering; pursues the same pharma and consumer naming RFPs and uses a similar creative-plus-strategy professional services model.

Emerging players

• Saffron Brand Consultants: Independent strategy-led brand consultancy with selective pharma/health work; smaller than Brand Institute but operating the same creative naming + brand strategy model for global enterprise clients.
• Corsearch: Trademark clearance and brand protection software platform that also offers naming clearance and screening services; a partial-overlap competitor to Brand Institute's in-house trademark department and an emerging player adding AI features.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@brandinstituteinc
• LinkedInlinkedin.com/company/brand-institute
• Xx.com/brandinstitute
• Facebookfacebook.com/brandinstituteinc

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brand Institute